Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 8/20 | 0.47 |
| ▸ | CYP2C8 | P10632 | 5/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10241973 | 1.00 | CYP3A4 (0.47) | CYP3A4CYP2C8KCNH2NR1I2CYP2C9 | |
| SCHEMBL13457679 | 0.93 | CYP3A4 (0.41) | CYP3A4CYP2C8KCNH2NR1I2FAAH | |
| SCHEMBL10240173 | 0.87 | CYP3A4 (0.51) | CYP3A4CYP2C8KCNH2NR1I2FAAH | |
| SCHEMBL10242040 | 0.85 | CYP3A4 (0.51) | CYP3A4CYP2C8KCNH2NR1I2FAAH | |
| SCHEMBL10240293 | 0.85 | CYP3A4 (0.53) | CYP3A4CYP2C8KCNH2NR1I2CYP2C9 | |
| SCHEMBL10240158 | 0.85 | CYP3A4 (0.51) | CYP3A4CYP2C8KCNH2NR1I2FAAH | |
| SCHEMBL10240161 | 0.85 | CYP3A4 (0.51) | CYP3A4CYP2C8KCNH2NR1I2FAAH | |
| SCHEMBL1918586 | 0.84 | CYP3A4 (0.45) | CYP3A4CYP2C8KCNH2NR1I2CYP2C9 | |
| SCHEMBL10280745 | 0.84 | CYP3A4 (0.45) | CYP3A4CYP2C8KCNH2NR1I2CYP2C9 | |
| SCHEMBL1918585 | 0.84 | CYP3A4 (0.45) | CYP3A4CYP2C8KCNH2NR1I2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2326633-B1 | COMPOUNDS FOR THE TREATMENT OF HEPATITIS C | BRISTOL MYERS SQUIBB CO (US) | 2015-12-16 | — | — | EP | disclosed |